KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Humana (HUM) EBIAT (2016 - 2025)

Humana has reported EBIAT over the past 17 years, most recently at -$796.0 million for Q4 2025.

  • Quarterly results put EBIAT at -$796.0 million for Q4 2025, down 15.36% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (down 1.99% YoY), and the annual figure for FY2025 was $1.2 billion, down 1.57%.
  • EBIAT for Q4 2025 was -$796.0 million at Humana, down from $194.0 million in the prior quarter.
  • Over the last five years, EBIAT for HUM hit a ceiling of $1.5 billion in Q3 2021 and a floor of -$796.0 million in Q4 2025.
  • Median EBIAT over the past 5 years was $687.5 million (2022), compared with a mean of $531.5 million.
  • Biggest five-year swings in EBIAT: skyrocketed 114.29% in 2022 and later plummeted 27400.0% in 2023.
  • Humana's EBIAT stood at -$14.0 million in 2021, then skyrocketed by 114.29% to $2.0 million in 2022, then plummeted by 27400.0% to -$546.0 million in 2023, then fell by 26.37% to -$690.0 million in 2024, then dropped by 15.36% to -$796.0 million in 2025.
  • The last three reported values for EBIAT were -$796.0 million (Q4 2025), $194.0 million (Q3 2025), and $543.0 million (Q2 2025) per Business Quant data.